Literature DB >> 23645660

T-cell prolymphocytic leukaemia (T-PLL): a rare disease with a grave prognosis.

Abhirami Vivekanandarajah1, Jean Paul Atallah, Shilpi Gupta.   

Abstract

T-cell prolymphocytic leukaemia (T-PLL) is an extremely uncommon haematological malignancy that has an aggressive course and a grave prognosis. We describe a patient who presented with lymphocytosis, scalp erythema, ascites and splenomegaly and was diagnosed with T-PLL. He was treated with alemtuzumab with a good response and was referred for allogeneic stem cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23645660      PMCID: PMC3669843          DOI: 10.1136/bcr-2013-009808

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Is there a T-cell form of chronic lymphocytic leukemia?

Authors:  K A Foon; R P Gale
Journal:  Leukemia       Date:  1992-09       Impact factor: 11.528

2.  How I treat prolymphocytic leukemia.

Authors:  Claire Dearden
Journal:  Blood       Date:  2012-05-30       Impact factor: 22.113

3.  Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia.

Authors:  E Matutes; V Brito-Babapulle; J Swansbury; J Ellis; R Morilla; C Dearden; A Sempere; D Catovsky
Journal:  Blood       Date:  1991-12-15       Impact factor: 22.113

4.  Treatment of T-cell prolymphocytic leukemia with human CD52 antibody.

Authors:  R Pawson; M J Dyer; R Barge; E Matutes; P D Thornton; E Emmett; J C Kluin-Nelemans; W E Fibbe; R Willemze; D Catovsky
Journal:  J Clin Oncol       Date:  1997-07       Impact factor: 44.544

5.  Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases.

Authors:  J L Preud'homme; M Seligmann
Journal:  Blood       Date:  1972-12       Impact factor: 22.113

6.  Nonmyeloablative peripheral blood stem cell transplant for T-cell prolymphocytic leukaemia complicated by fulminant haemolysis and acute renal failure at engraftment secondary to minor ABO incompatibility.

Authors:  N J Curtin; A P Schwarer
Journal:  Clin Lab Haematol       Date:  2005-06

7.  High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H.

Authors:  C E Dearden; E Matutes; B Cazin; G E Tjønnfjord; A Parreira; B Nomdedeu; P Leoni; F J Clark; D Radia; S M Rassam; T Roques; N Ketterer; V Brito-Babapulle; M J Dyer; D Catovsky
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

8.  Abnormalities of chromosomes 8, 11, 14, and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization.

Authors:  S H Maljaei; V Brito-Babapulle; L R Hiorns; D Catovsky
Journal:  Cancer Genet Cytogenet       Date:  1998-06

Review 9.  T-small lymphocyte disorders.

Authors:  N L Bartlett; D L Longo
Journal:  Semin Hematol       Date:  1999-04       Impact factor: 3.851

10.  "T-cell prolymphocytic leukemia (T-PLL), a heterogeneous disease exemplified by two cases and the important role of cytogenetics: a multidisciplinary approach".

Authors:  Carlos A Tirado; Phillip Starshak; Paul Delgado; Nagesh Rao
Journal:  Exp Hematol Oncol       Date:  2012-08-20
View more
  2 in total

1.  A patient with white blood cell counts more than a million: A diagnostic and therapeutic challenge.

Authors:  Luis A Figueroa-Jiménez; Amy Lee Cabrera-Márquez; Luis Báez-Díaz; William Cáceres-Perkins
Journal:  Bisturi (S Juan)       Date:  2016 Mar-Jun

2.  Exploring the molecular pathogenesis associated with T-cell prolymphocytic leukemia based on a comprehensive bioinformatics analysis.

Authors:  Zhangzhen Shi; Jing Yu; Hui Shao; Kailiang Cheng; Jingjie Zhai; Qi Jiang; Hongjun Li
Journal:  Oncol Lett       Date:  2018-05-02       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.